Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker WVE
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Aug 12, 2026 | Adrian Rawcliffe Director | WVE Wave Life Sciences, Inc. | Sale | 12,700 | $5.29 | $67.2K Sale | Form 4 ↗ |
| Aug 11, 2026 | Heidi L. Wagner Director | WVE Wave Life Sciences, Inc. | Sale | 7,000 | $6.01 | $42.1K Sale | Form 4 ↗ |
| Aug 11, 2026 | Ken Takanashi Director | WVE Wave Life Sciences, Inc. | Sale | 3,864 | $6.01 | $23.2K Sale | Form 4 ↗ |
| Aug 11, 2026 | Tan Aik Na Director | WVE Wave Life Sciences, Inc. | Sale | 432 | $6.01 | $2,596 Sale | Form 4 ↗ |
| Mar 30, 2026 | Ra Capital Management, L.P. Director, 10% owner | WVE Wave Life Sciences, Inc. | Buy | 971,091 | $6.50 | $6.3M Buy | Form 4 ↗ |
| Mar 27, 2026 | Ra Capital Management, L.P. Director, 10% owner | WVE Wave Life Sciences, Inc. | Buy | 2.50M | $6.43 | $16.0M Buy | Form 4 ↗ |
| Mar 26, 2026 | Ra Capital Management, L.P. Director, 10% owner | WVE Wave Life Sciences, Inc. | Buy | 351,224 | $6.38 | $2.2M Buy | Form 4 ↗ |
| Mar 26, 2026 | Ra Capital Management, L.P. Director, 10% owner | WVE Wave Life Sciences, Inc. | Buy | 4.95M | $6.06 | $30.0M Buy | Form 4 ↗ |
| Feb 26, 2026 | Chris Francis See Remarks | WVE Wave Life Sciences, Inc. | Sale | 15,294 | $15.00 | $229.4K Sale | Form 4 ↗ |
| Feb 26, 2026 | Chris Francis See Remarks | WVE Wave Life Sciences, Inc. | Sale | 17,900 | $15.09 | $270.1K Sale | Form 4 ↗ |
| Feb 9, 2026 | Kyle Moran Chief Financial Officer | WVE Wave Life Sciences, Inc. | Sale | 3,588 | $13.45 | $48.3K Sale | Form 4 ↗ |
| Feb 9, 2026 | Paul Bolno President and CEO, Director | WVE Wave Life Sciences, Inc. | Sale | 10,480 | $13.45 | $141.0K Sale | Form 4 ↗ |
| Feb 9, 2026 | Chris Francis See Remarks | WVE Wave Life Sciences, Inc. | Sale | 1,883 | $13.45 | $25.3K Sale | Form 4 ↗ |
| Feb 9, 2026 | Chandra Vargeese See Remarks | WVE Wave Life Sciences, Inc. | Sale | 3,228 | $13.45 | $43.4K Sale | Form 4 ↗ |
| Jan 2, 2026 | Chris Francis See Remarks | WVE Wave Life Sciences, Inc. | Sale | 1,295 | $16.70 | $21.6K Sale | Form 4 ↗ |
| Jan 2, 2026 | Chris Francis See Remarks | WVE Wave Life Sciences, Inc. | Sale | 8,080 | $15.92 | $128.6K Sale | Form 4 ↗ |
| Dec 11, 2025 | GSK plc 10% owner | WVE Wave Life Sciences, Inc. | Buy | 1.47M | $19.00 | $27.9M Buy | Form 4 ↗ |
| Dec 9, 2025 | Kyle Moran Chief Financial Officer | WVE Wave Life Sciences, Inc. | Sale | 50,000 | $20.03 | $1.0M Sale | Form 4 ↗ |
| Dec 9, 2025 | Kyle Moran Chief Financial Officer | WVE Wave Life Sciences, Inc. | Sale | 36 | $20.25 | $729 Sale | Form 4 ↗ |
| Dec 8, 2025 | Adrian Rawcliffe Director | WVE Wave Life Sciences, Inc. | Sale | 42,000 | $15.00 | $630.0K Sale | Form 4 ↗ |
| Dec 8, 2025 | Heidi L. Wagner Director | WVE Wave Life Sciences, Inc. | Sale | 7,000 | $14.00 | $98.0K Sale | Form 4 ↗ |
| Dec 8, 2025 | Heidi L. Wagner Director | WVE Wave Life Sciences, Inc. | Sale | 7,000 | $13.00 | $91.0K Sale | Form 4 ↗ |
| Dec 8, 2025 | Christian O. Henry Director | WVE Wave Life Sciences, Inc. | Sale | 30,000 | $18.02 | $540.6K Sale | Form 4 ↗ |
| Dec 8, 2025 | Christian O. Henry Director | WVE Wave Life Sciences, Inc. | Sale | 15,000 | $14.07 | $211.1K Sale | Form 4 ↗ |
| Dec 8, 2025 | Christian O. Henry Director | WVE Wave Life Sciences, Inc. | Sale | 42,000 | $12.75 | $535.5K Sale | Form 4 ↗ |
| Dec 8, 2025 | Christian O. Henry Director | WVE Wave Life Sciences, Inc. | Sale | 6,445 | $12.75 | $82.2K Sale | Form 4 ↗ |
| Dec 8, 2025 | Tan Aik Na Director | WVE Wave Life Sciences, Inc. | Sale | 21,000 | $12.75 | $267.8K Sale | Form 4 ↗ |
| Dec 8, 2025 | Tan Aik Na Director | WVE Wave Life Sciences, Inc. | Sale | 21,000 | $12.75 | $267.8K Sale | Form 4 ↗ |
| Dec 8, 2025 | Tan Aik Na Director | WVE Wave Life Sciences, Inc. | Sale | 25,000 | $15.00 | $375.0K Sale | Form 4 ↗ |
| Dec 8, 2025 | Tan Aik Na Director | WVE Wave Life Sciences, Inc. | Sale | 20,000 | $12.75 | $255.0K Sale | Form 4 ↗ |
| Dec 8, 2025 | Tan Aik Na Director | WVE Wave Life Sciences, Inc. | Sale | 17,230 | $15.00 | $258.4K Sale | Form 4 ↗ |
| Dec 8, 2025 | Tan Aik Na Director | WVE Wave Life Sciences, Inc. | Sale | 15,000 | $12.75 | $191.3K Sale | Form 4 ↗ |
| Dec 8, 2025 | Tan Aik Na Director | WVE Wave Life Sciences, Inc. | Sale | 7,494 | $15.00 | $112.4K Sale | Form 4 ↗ |
| Dec 8, 2025 | Tan Aik Na Director | WVE Wave Life Sciences, Inc. | Sale | 7,494 | $12.75 | $95.5K Sale | Form 4 ↗ |
| Dec 8, 2025 | Gregory L. Verdine Director | WVE Wave Life Sciences, Inc. | Sale | 7,980 | $14.05 | $112.1K Sale | Form 4 ↗ |
| Dec 8, 2025 | Gregory L. Verdine Director | WVE Wave Life Sciences, Inc. | Sale | 12,020 | $13.09 | $157.3K Sale | Form 4 ↗ |
| Dec 8, 2025 | Chris Francis See Remarks | WVE Wave Life Sciences, Inc. | Sale | 22,500 | $14.08 | $316.8K Sale | Form 4 ↗ |
| Dec 8, 2025 | Chris Francis See Remarks | WVE Wave Life Sciences, Inc. | Sale | 50,000 | $16.00 | $800.0K Sale | Form 4 ↗ |
| Dec 8, 2025 | Chris Francis See Remarks | WVE Wave Life Sciences, Inc. | Sale | 122,349 | $14.20 | $1.7M Sale | Form 4 ↗ |
| Dec 8, 2025 | Chris Francis See Remarks | WVE Wave Life Sciences, Inc. | Sale | 17,900 | $15.00 | $268.5K Sale | Form 4 ↗ |
| Dec 8, 2025 | Chris Francis See Remarks | WVE Wave Life Sciences, Inc. | Sale | 37,500 | $14.08 | $528.0K Sale | Form 4 ↗ |
| Dec 8, 2025 | Chris Francis See Remarks | WVE Wave Life Sciences, Inc. | Sale | 9,375 | $15.00 | $140.6K Sale | Form 4 ↗ |
| Dec 8, 2025 | Chris Francis See Remarks | WVE Wave Life Sciences, Inc. | Sale | 45,882 | $14.50 | $665.3K Sale | Form 4 ↗ |
| Dec 8, 2025 | Chris Francis See Remarks | WVE Wave Life Sciences, Inc. | Sale | 107,400 | $14.56 | $1.6M Sale | Form 4 ↗ |
| Dec 8, 2025 | Chris Francis See Remarks | WVE Wave Life Sciences, Inc. | Sale | 28,125 | $14.50 | $407.8K Sale | Form 4 ↗ |
| Dec 8, 2025 | Kyle Moran Chief Financial Officer | WVE Wave Life Sciences, Inc. | Sale | 50,000 | $18.00 | $900.0K Sale | Form 4 ↗ |
| Dec 8, 2025 | Kyle Moran Chief Financial Officer | WVE Wave Life Sciences, Inc. | Sale | 50,000 | $13.20 | $660.0K Sale | Form 4 ↗ |
| Dec 8, 2025 | Kyle Moran Chief Financial Officer | WVE Wave Life Sciences, Inc. | Sale | 50,000 | $15.00 | $750.0K Sale | Form 4 ↗ |
| Dec 8, 2025 | Kyle Moran Chief Financial Officer | WVE Wave Life Sciences, Inc. | Sale | 60,000 | $13.20 | $792.0K Sale | Form 4 ↗ |
| Dec 8, 2025 | Mark Corrigan Director | WVE Wave Life Sciences, Inc. | Sale | 6,515 | $14.07 | $91.7K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:15 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances